ArthroCare Overview

ArthroCare’s (NASDAQ: ARTC) mission is to design surgical instruments that will improve patient outcomes by using our internationally patented Coblation™ technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. Coblation significantly improves many existing surgical procedures and enables new minimally invasive procedures. We have created a...More»

ArthroCare’s (NASDAQ: ARTC) mission is to design surgical instruments that will improve patient outcomes by using our internationally patented Coblation™ technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. Coblation significantly improves many existing surgical procedures and enables new minimally invasive procedures. We have created a multi-business medical device company around this platform technology — developing, manufacturing and marketing products for a variety of soft tissue surgical applications. ArthroCare is leveraging Coblation technology to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including arthroscopy; spine and neurology; ear, nose and throat; cosmetic; urology; gynecology; and laparoscopy/general surgery.«Less